A diagnostic device designed to read and interpret rapid test results from point-of-care test cartridges. The reader provides automated analysis and result reporting for rapid diagnostic tests.
Manufactured by
Shanghai Chemtron Biotech Co.,Ltd.
Shanghai, China
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R D, production, sales and services of in-vitro rapid detection of diagnostic reagents. Chemtron has Production Plants over 17000 square meters with facilities for advanced R D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States. Chemtron has established a first-class “Chemtron R D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a series of in-vitro diagnostic reagents under the national registered trademark Chemtrue , with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products. Chemtron has always adhered to the business philosophy of quality, reputation, service and sincerity and the quality policy of perfect quality, standardized management, innovation and sincere service . Chemtron s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Response Biomedical
Canada · 1 relevant product
Reagena Oy
Finland · 2 relevant products
Operon S.A.
Spain · 1 relevant product
10 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 16 closest product alternatives
Response Biomedical · Canada
Portable reader device for point of care diagnostic test cartridges. Provides quantitative results and data management capabilities for clinical decision support.
Reagena Oy · Finland
A reader device and related accessories designed to work with the ReaScan® + rapid test platform for point-of-care diagnostic testing. The system enables automated or semi-automated reading and interpretation of rapid test results.
Reagena Oy · Finland
A reader device used in conjunction with ReaScan®+ rapid tests for reading and interpreting test results. The reader is part of the ReaScan®+ product family and includes related accessories.
13 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products